首页> 美国卫生研究院文献>other >An improved DNA array-based classification method for the identification of Salmonella serotypes shows high concordance between traditional and genotypic testing
【2h】

An improved DNA array-based classification method for the identification of Salmonella serotypes shows high concordance between traditional and genotypic testing

机译:一种改进的基于DNA阵列的沙门氏菌血清型识别分类方法显示了传统检测与基因型检测之间的高度一致性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Previously we developed and tested the Salmonella GenoSerotyping Array (SGSA), which utilized oligonucleotide probes for O- and H- antigen biomarkers to perform accurate molecular serotyping of 57 Salmonella serotypes. Here we describe the development and validation of the ISO 17025 accredited second version of the SGSA (SGSA v. 2) with reliable and unambiguous molecular serotyping results for 112 serotypes of Salmonella which were verified both in silico and in vitro. Improvements included an expansion of the probe sets along with a new classifier tool for prediction of individual antigens and overall serotype from the array probe intensity results. The array classifier and probe sequences were validated in silico to high concordance using 36,153 draft genomes of diverse Salmonella serotypes assembled from public repositories. We obtained correct and unambiguous serotype assignments for 31,924 (88.30%) of the tested samples and a further 3,916 (10.83%) had fully concordant antigen predictions but could not be assigned to a single serotype. The SGSA v. 2 can directly use bacterial colonies with a limit of detection of 860 CFU/mL or purified DNA template at a concentration of 1.0 x 10−1 ng/μl. The SGSA v. 2 was also validated in the wet laboratory and certified using panel of 406 samples representing 185 different serotypes with correct antigen and serotype determinations for 60.89% of the panel and 18.31% correctly identified but an ambiguous overall serotype determination.
机译:以前,我们开发并测试了沙门氏菌基因分型阵列(SGSA),该阵列利用O型和H型抗原生物标记物的寡核苷酸探针对57种沙门氏菌血清型进行准确的分子分型。在这里,我们描述了经ISO 17025认证的第二版SGSA(SGSA v。2)的开发和验证,该产品具有112种血清型沙门氏菌的可靠且明确的分子血清分型结果,这些结果已在计算机和体外进行了验证。改进包括扩展探针集,以及新的分类器工具,可根据阵列探针强度结果预测单个抗原和总体血清型。阵列分类器和探针序列在计算机上使用从公共存储库组装的36,153种不同沙门氏菌血清型的基因组草图进行了计算机高度验证。我们为31,924(88.30%)个测试样品获得了正确且明确的血清型分配,另外3,916(10.83%)个具有完全一致的抗原预测,但无法分配给单个血清型。 SGSA v。2可以直接使用细菌菌落,检测限为860 CFU / mL或纯化的DNA模板,浓度为1.0 x 10 -1 ng /μl。 SGSA v。2也已在湿实验室中进行了验证,并使用代表185种不同血清型的406个样本小组进行了认证,其中60.89%的小组有正确的抗原和血清型测定,正确鉴定的18.31%,但总体血清型测定模棱两可。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号